CEL-SCI CORPORATION Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
CEL-SCI CORPORATION (CVM) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 1.22 thousand shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-08-14
- CEL-SCI CORPORATION share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-06-30 was 1.22K shares, a 88.97% decline year-over-year.
- CEL-SCI CORPORATION share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-03-31 was 0.00 shares, a 100.00% decline year-over-year.
- CEL-SCI CORPORATION share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-12-31 was 565.00 shares, a 7.01% increase year-over-year.
- CEL-SCI CORPORATION share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-06-30 was 11.03K shares, a 37.91% increase year-over-year.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | 1.22K shares 10-Q · filed 2026-08-14 | 1.22K shares derived: sum of 2 quarters · filed 2026-08-14 | 1.78K shares 10-Q · filed 2026-08-14 | |||
| 2026-03-31 | 0.00 shares 10-Q · filed 2026-05-15 | 565.00 shares 10-Q · filed 2026-05-15 | ||||
| 2025-12-31 | 565.00 shares 10-Q · filed 2026-02-17 | |||||
| 2025-06-30 | 11.03K shares 10-Q · filed 2026-08-14 | 11.43K shares derived: sum of 2 quarters · filed 2026-08-14 | 11.96K shares 10-Q · filed 2026-08-14 | |||
| 2025-03-31 | 395.00 shares 10-Q · filed 2026-05-15 | 11.83K shares 10-Q · filed 2025-05-14 | 922.00 shares 10-Q · filed 2026-05-15 | 27.67K shares 10-Q · filed 2025-05-14 | ||
| 2024-12-31 | 528.00 shares 10-Q · filed 2026-02-17 | 15.83K shares 10-Q · filed 2025-02-14 | ||||
| 2024-06-30 | 8.00K shares 10-Q · filed 2025-08-14 | 240.00K shares 10-Q · filed 2024-08-14 | 50.00K shares derived: sum of 2 quarters · filed 2025-08-14 | 9.77K shares 10-Q · filed 2025-08-14 | 293.00K shares 10-Q · filed 2024-08-14 | |
| 2024-03-31 | 42.00K shares 10-Q · filed 2025-05-14 | 53.00K shares 10-Q · filed 2025-05-14 | ||||
| 2023-12-31 | 11.00K shares 10-Q · filed 2025-02-14 | |||||
| 2023-06-30 | 57.50K shares 10-Q · filed 2024-08-14 | 83.00K shares derived: sum of 2 quarters · filed 2024-08-14 | 179.83K shares 10-Q · filed 2024-08-14 | |||
| 2023-03-31 | 25.50K shares 10-Q · filed 2024-05-15 | 122.33K shares 10-Q · filed 2024-05-15 | ||||
| 2022-12-31 | 96.83K shares 10-Q · filed 2024-02-14 | |||||
| 2022-06-30 | 0.00 shares 10-Q · filed 2022-08-12 | 7.17K shares derived: sum of 2 quarters · filed 2023-05-12 | 20.17K shares 10-Q · filed 2023-08-10 | |||
| 2022-03-31 | 7.17K shares 10-Q · filed 2023-05-12 | 20.17K shares 10-Q · filed 2023-05-12 | ||||
| 2021-12-31 | 13.00K shares 10-Q · filed 2023-02-14 | |||||
| 2021-06-30 | 0.00 shares 10-Q · filed 2022-08-12 | 0.00 shares derived: sum of 2 quarters · filed 2022-08-12 | 42.17K shares 10-Q · filed 2022-08-12 | |||
| 2021-03-31 | 0.00 shares 10-Q · filed 2022-05-13 | 42.16K shares 10-Q · filed 2022-05-13 | ||||
| 2020-12-31 | 42.17K shares 10-Q · filed 2022-02-11 | |||||
| 2020-06-30 | 16.00 shares 10-Q · filed 2021-08-13 | 1.02K shares derived: sum of 2 quarters · filed 2021-08-13 | 1.00K shares 10-Q · filed 2021-08-13 | 1.18K shares 10-Q/A · filed 2020-08-11 | ||
| 2020-03-31 | 1.00K shares 10-Q · filed 2021-05-17 | 1.00K shares 10-Q · filed 2021-05-17 | ||||
| 2019-06-30 | 39.51K shares 10-Q/A · filed 2020-12-31 | 63.70K shares derived: sum of 2 quarters · filed 2020-12-31 | 63.70K shares 10-Q/A · filed 2020-12-31 | |||
| 2019-03-31 | 24.19K shares 10-Q/A · filed 2020-12-30 | 24.19K shares 10-Q/A · filed 2020-12-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |